Yunnan Industrial Investment Holding Group

What Yunnan Industrial Investment Holding Group does

Yunnan Industrial Investment Holding Group is a provincial state-owned conglomerate under the Yunnan Provincial State-owned Assets Supervision and Administration Commission (SASAC), established in February 2008 through the consolidation of five state-owned industrial enterprises. The group operates a '1+3+X' industrial layout spanning four primary business segments: bio-pharmaceuticals and healthcare (anchored by Yunnan Plant Pharmaceutical and Yunnan Bohao Biotechnology), information technology (anchored by Shenzhen-listed Yunnan Nantian Electronic Information, stock code 000948), industrial parks and asset management, and financial services support. As of end-2024, the group managed 19 wholly-owned and controlled enterprises with approximately 12,460 employees, 422.8 billion RMB in total assets, and 150 billion RMB in annual revenue.

The bio-pharmaceutical segment includes Yunnan Plant Pharmaceutical (23 dosage forms, 286 product varieties, 439 approval numbers, 137 patents) producing plant-based medicines including Yunnan Red Medicine Capsule and Qu Shi Ke Li (Dampness Removal Granules), plus Yunnan Bohao Biotechnology, the world's largest marigold lutein supplier with ~40% global market share exporting to 20+ countries. The information technology segment, delivered through Nantian Information with 40+ years of financial IT expertise, provides core banking systems, distributed Xin Chuang (domestic IT substitution) architectures, risk strategy platforms (99.99% execution rate), and a full-stack AI product portfolio including ChatTask 2.0, Huifu AI, Lingjian Tong 4.0, with deep integration into Huawei (HarmonyOS, Ascend), Alibaba Cloud (Qwen), and DeepSeek ecosystems. The industrial parks segment develops bonded zones, creative economy parks, and asset management across Kunming, Qujing, Zhaotong, Dali, and Tengchong, while the financial services arm provides guarantee, property exchange, and fund management services.

The group's revenue model is multi-stream and diversified: bio-pharma revenue flows through hospital channels, retail pharmacies, commercial distributors, and direct e-commerce; IT revenue is generated via project-based systems integration, software licensing, and lifecycle services to financial institutions and government/enterprise clients; industrial parks generate lease, management, and co-development revenue; financial services earn transaction and guarantee fees. The group pursues B2B sales-led go-to-market across segments, with provincial SOE status providing regulatory advantages, preferential government contracts, and policy alignment with national industrial development priorities including domestic IT substitution (Xin Chuang), traditional Chinese medicine modernization, and rural agricultural value chain integration supporting 100,000+ farmer households.

Name

Yunnan Industrial Investment Holding Group

Legal name

云南省工业投资控股集团有限责任公司

Website

https://ygtgp.com

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

11–50 employees

Short description

Yunnan Industrial Investment Holding Group is a provincial state-owned conglomerate operating bio-pharmaceuticals (Yunnan Plant Pharmaceutical, Bohao Biotechnology), financial IT (Nantian Information), industrial parks, and financial services across China and 20+ export markets.

Ownership category

akta.pro rank

Product category

Diversified Industrial Holding (Pharmaceuticals, Financial IT, Industrial Parks)

NAICS

Miscellaneous Financial Investment Activities (523999), Medicinal and Botanical Manufacturing (325411), Management of Companies and Enterprises (551)

SIC

Investors, Nec (6799), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Corporate Innovation & Technology Scouting Units (with investment mandate) (FSANAHAI)

akta.pro secondary industries

Industrials & Manufacturing Growth Equity (FSANACAF), Industrial Park Owners Association Management (BPAJAHAH)

Keywords

• Plant pharmaceutical manufacturing
• Financial IT solutions
• Industrial park development
• Natural plant extracts
• Financing guarantee services

Headquarters

HQ city

Kunming

HQ country

China

HQ region

Asia

Offices8 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Infrastructure, Marketing or Sales

Revenue model

1. Bio-pharmaceutical Manufacturing and Sales: Revenue from manufacturing and selling of plant-based pharmaceuticals, chemical drugs, medical devices, and health products through Yunnan Plant Pharmaceutical and other pharma subsidiaries. Sales through hospital channels, retail pharmacies, commercial distributors, and online platforms.
2. Natural Plant Extracts Export: Revenue from producing and exporting marigold lutein,辣椒红 (capsanthin), and other plant extracts via Yunnan Bohao Biotechnology. Over 70% of products exported to Europe, US, Japan, South Korea and 20+ countries. Global lutein product market share approximately 40%.
3. Pharmaceutical Distribution: Revenue from pharmaceutical wholesale and retail distribution via Yunnan Pharmaceutical Industrial Sales Co., Ltd., operating over 10,000 pharmaceutical product varieties with province-wide sales network coverage.
4. IT Solutions and Services: Revenue from software development, hardware manufacturing, system integration, and IT lifecycle services via Yunnan Nantian Electronic Information Industry (stock code 000948), serving financial institutions and government/enterprise clients.
5. Industrial Park Development and Asset Management: Revenue from industrial park development, asset operation, and management via Yunnan Tongtu Park Industrial Investment and Yunnan National Assets Kunming Economic Development Zone Industrial Development. Also rental income from land holdings (approximately 4,000 mu) and property assets (approximately 270,000 sqm).
6. Financial Services: Revenue from financial guarantee services via Yunnan Provincial Investment Financing Guarantee Co., Ltd. (AA+ credit rating) and property rights exchange services via Yunnan Property Rights Exchange Group.

Pricing tiers

Go-to-market motion3 records

Distribution channels6 records

Marketing channels8 records

Core offering

Yunnan Industrial Investment Holding Group is a provincial state-owned conglomerate that develops and sells plant-based pharmaceuticals and natural plant extracts (via Yunnan Plant Pharmaceutical and Bohao Biotechnology), delivers financial IT solutions and AI platforms (via Nantian Information, stock code 000948), develops and operates industrial parks, and provides financing guarantee and property rights exchange services. The group's products are sold to banks, hospitals, pharmaceutical distributors, government agencies, and large enterprises both domestically and internationally.

Product overview

云南省工业投资控股集团有限责任公司（工投集团）是云南省属国有重要骨干企业，围绕"1+3+X"产业布局，聚焦生物医药大健康、信息产业、产业园区、金融服务支撑四大主营业务板块，旗下拥有多家上市公司和专业化企业。信息产业板块以云南南天电子信息产业股份有限公司为核心，提供金融IT系统全生命周期服务及全栈AI产品矩阵（含ChatTask AI Agent平台、慧府AI应用平台、灵鉴通智能音视频平台等）；生物医药板块以云南植物药业有限公司和云南博浩生物科技集团股份有限公司为核心，前者专注植物药提取及中成药/化学药制剂（云南红药胶囊、血塞通系列等），后者是全球最大的万寿菊叶黄素供应商并延伸至终端功能性食品；产业园区板块运营工业地产及资产运营管理；金融服务板块提供融资担保、产权交易等服务。各板块协同联动，共同构成以工业为本的多元化实业集团。

Differentiator

Problem solved

Functional benefit

Brands

• 生物医药大健康板块 (Bio-pharmaceuticals & Healthcare): Group's bio-pharmaceuticals and healthcare business segment encompassing Yunnan Plant Pharmaceutical, Yunnan Bohao Bio, Yunnan Rainbow Bio-Tech, Yunnan Pharmaceutical Sales, Industrial Hemp Investment, and pharmaceutical investment platforms.
• 信息产业板块 (Information Technology)
• 产业园区板块 (Industrial Parks)
• 金融服务支撑板块 (Financial Services)
• 云植 (Yunzhi / Cloud Plant)
• 东方 (Dongfang)
• 南天信息 (Nantian Information)
• 博浩 (Bohao)

Products and services

• Yunnan Plant Pharmaceutical Drug Product Line Modernized pharmaceutical manufacturing of plant-based drugs, Chinese patent medicines, chemical drugs, medical devices, and health foods across 23 dosage forms with 286 varieties and 439 approval numbers. Core products include Yunnan Red Medicine Capsule, Xue Saitong series, Deng Zhan Xi Xin Granules, Qu Shi Ke Li, and carboplatin injection. The product line serves hospitals, pharmacies, distributors, and consumers across 30 provinces in China.
• Bohao Biotechnology Marigold Lutein Products Marigold-derived natural lutein products including lutein crystals, lutein ester oil suspensions, microcapsules, and extended functional food products like lutein soft capsules and lutein ester grape sugar zinc soft capsules. Bohao Biotechnology is the world's largest marigold planting and lutein production enterprise, with over 70% of products exported to Europe, US, Japan, South Korea and 20+ countries.
• Nantian Information Financial IT Systems End-to-end financial IT lifecycle solutions for financial institutions including core banking systems, convenient payment platforms (largest scale payment platform in China), cloud Zhi Wei operations middle platform, intelligent risk control systems, intelligent marketing systems, full-stack Xin Chuang cloud platform, and unified payment platform. Deployed at major state-owned commercial banks, joint-stock banks, urban commercial banks, rural credit cooperatives, insurance companies, and asset management firms.
• Nantian ChatTask AI Agent Assistant Platform Operation control and evaluation component library for financial industry intelligent agents, focusing on task routing, state management, Agent collaboration, governance control, observable monitoring, and decision evaluation. Supports safe, controllable, and stable operation of complex AI systems in financial scenarios.
• Nantian Huifu AI Application Platform Enterprise-grade agile AI application platform for SMEs and financial institutions with AI base large model and computing as underlying support, providing differentiated knowledge Q&A and AI intelligent agent services across customer service, risk control, marketing, and office scenarios.
• Ling Jian Tong Intelligent Audio-Video Application Platform 4.0 Intelligent audio-video application platform for remote interaction, full-process traceability, full-link compliance risk control, and intelligent services. Provides remote identity verification, audio-video multi-modal intelligent analysis, real-time compliance scoring, intelligent compliance guidance, and real-time violation early warning for financial industry audio-video applications.
• Nantian Enterprise-Level Risk Strategy Platform Enterprise-level risk strategy platform for banking industry risk control systems with 99.99% strategy execution success rate. Deployed at major Chinese banks including industrial and commercial banks for risk management and regulatory compliance.
• Nantian Xin Chuang Printer, Server, and PC Product Line Xin Chuang (domestic IT substitution) hardware products including Xin Chuang printers with domestic chips (32 pages/minute print speed), Xin Chuang servers, and Xin Chuang PCs. Targets domestic IT substitution mandates in Chinese government and state-owned enterprises with 440+ product adaptation certifications.
• Yunnan Radio Nuclear-Biochemical Monitoring Systems Nuclear-biochemical monitoring/alarm devices, special vehicles, information processing centers, three-defense control systems, and civil defense engineering. Produced by Yunnan Radio Co., Ltd., a backbone defense electronic equipment enterprise and national/provincial 'specialized, refined, distinctive, novel' small giant enterprise.
• Bohao Biotechnology Capsanthin and Other Plant Pigment Products Water-soluble natural plant pigment products including capsanthin, gardenia yellow, and radish red. Over 70% of products exported to Europe, US, Japan, Korea and 20+ countries and regions for food, beverage, cosmetics, and pharmaceutical industries.
• Yunnan Pharmaceutical Industrial Sales Distribution Services Wholesale and retail pharmaceutical distribution operating over 10,000 pharmaceutical product varieties with province-wide sales network coverage. Distributes Yunnan Plant Pharmaceutical's products and other pharma brands across 30 provinces in China through commercial customers, hospital clinics, and retail terminals.
• Industrial Park Development and Asset Management Industrial park development, asset operation, and management including Kunming Comprehensive Bonded Zone Area A, Qujing People's Commune, Zhaotong Zhaoyang Industrial New Town, Dali Creative Economy Park, Tengchong Story, Shibo Li Park, and Yun Che Center (Cloud Car Center). Also manages approximately 4,000 mu of land holdings and approximately 270,000 sqm of property assets.
• Yunnan Provincial Investment and Financing Guarantee Services Professional financing guarantee services with AA+ credit rating. One of the few AA+ credit-rated guarantee institutions in Yunnan Province. Supports SMEs and provincial economic development through guarantee issuance and credit enhancement services.
• Yunnan Property Rights Exchange Services Equity, property rights, creditor rights, intellectual property, and forest rights transactions serving as the designated institution for SOE restructuring and state-owned asset transactions in Yunnan Province.

Quantifiable outcome

• Yunnan Plant Pharmaceutical achieved 13% average annual revenue growth and 37.6% average annual profit growth during the 14th Five-Year Plan period
• +4 more outcomes

Named customers14 records

Segments5 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability15 records

Feature6 records

Partnerships

13 partnerships are on record, tiered core and minor.

• 阿里云 (Alibaba Cloud)coreTechnology or Integration · 1 April 2026Nantian Information joined the Alibaba Cloud Financial AI Alliance, receiving new certification from nearly 100 partners. Participating in the 'Super Intelligent Agent Plan' jointly launched by Alibaba Cloud and ecosystem partners. Based on Alibaba Cloud Qwen large model, built AI large model application platform and general intelligent agent project for an asset management company, addressing core data fragmentation and lack of standardized RAG knowledge base challenges.
• 一心堂药业集团 (Yixuntang Pharmacy Group)coreChannel Partner/ Reseller/ Distributor · 1 April 2026Yunnan Plant Pharmaceutical entered comprehensive strategic cooperation with Yixuntang on the推广 and distribution of祛湿颗粒 (Dampness Removal Granules). Yixuntang invited Yunnan Plant Pharmaceutical as a key cooperation enterprise under its 'Xin Yao Plan' (Star Bright Plan) strategy, targeting joint exploration of the health dampness category market.
• 华为技术有限公司 (Huawei Technologies)coreTechnology or Integration · 1 January 2023Nantian Information is Huawei's important strategic partner and highest-level certified service provider. Deep collaboration spans cloud computing, HarmonyOS ecosystem, Ascend AI, and Xin Chuang (information innovation) core areas. Nantian developed dual certification as HarmonyOS development and ecosystem service provider, and jointly built the Yunnan Provincial State-owned Enterprise Xin Chuang Lab. Joint innovation on Xin Chuang printers, servers, and PCs with domestic chip support.
• 北京通用人工智能研究院 (Beijing Institute of General Artificial Intelligence)coreStrategic or Co-development PartnerNantian Information co-founded the '通智行业大脑' (Tongzhi Industry Brain) Alliance with Beijing Institute of General AI, China Tower, Kunlun Digital Intelligence, China Civil Aviation Information Group, Zhongguancun Science City Brain, and others. The alliance focuses on value alignment, neuro-symbolic-logic fusion, and industry trusted evolution for AI agents.
• 云南白药集团中药资源有限公司 (Yunnan Baiyao Group Chinese Medicine Resources Co., Ltd.)minorStrategic or Co-development PartnerSince 2024, Yunnan Plant Pharmaceutical has cooperated with Yunnan Baiyao Group Chinese Medicine Resources Co., Ltd. on Chinese medicine resource industry collaborative development, expanding its industry chain layout.
• 各国有商业银行 (State-owned Commercial Banks)coreChannel Partner/ Reseller/ DistributorNantian Information has long-standing partnerships with major state-owned banks including Industrial and Commercial Bank of China, providing core banking systems, distributed Xin Chuang core systems, risk strategy platforms, and intelligent marketing systems. First to build a new generation personal business distributed core system on full domestic tech stack for a major state-owned bank in 2022.
• 贵州百灵企业集团制药股份有限公司 (Guizhou Bailing Group Pharmaceutical Co., Ltd.)coreStrategic or Co-development PartnerIn 2018, Yunnan Plant Pharmaceutical introduced Guizhou Bailing Group as a strategic partner, achieving resource sharing and complementary advantages. Bailing's investment supported Yunnan Plant Pharmaceutical's modernization and development into a new stage.
• 云南省重点生物医药企业联盟 (云药联盟, Yunnan Key Bio-pharmaceutical Enterprise Alliance)minorStrategic or Co-development PartnerIn 2025, Yunnan Plant Pharmaceutical became one of 12 founding units and a council member of the Yunnan Key Bio-pharmaceutical Enterprise Alliance, working with other key bio-pharma enterprises to build an industrial collaborative development ecosystem for the entire 'Yunnan Medicine' value chain.
• 中国长江三峡集团有限公司 (China Three Gorges Group)coreTechnology or IntegrationNantian Information partnered with Three Gorges Group to create a smart investment management system, winning industry technology awards. Achieved industry-first 'AI + Investment Business' new model, deploying DeepSeek for office scenario AI transformation. Also developed AI intelligent agent embedded in asset lifecycle management for a large asset management company.
• 天猫养车 (Tmall Auto Service)minorChannel Partner/ Reseller/ DistributorYun Che Center (Cloud Car Center) at the Shibo Li (世博里) Park has introduced Tmall Auto Service as an automotive after-market tenant, providing EV charging, maintenance, and related services.
• 洲际酒店集团 (InterContinental Hotels Group)minorChannel Partner/ Reseller/ DistributorYunnan Tongtai Park Industrial Investment's sub-company Yunnan Tongtai Construction Co., Ltd. entered strategic cooperation with InterContinental Hotels Group to introduce the Holiday Inn Express brand into the Kunming Shibo Li (世博里) project via franchise model.
• 新希望新服集团 (New Hope New Service Group)minorChannel Partner/ Reseller/ DistributorThe Kunming Shibo Li (世博里) project introduced professional operator New Hope New Service Group for asset management, effectively alleviating initial investment capital pressure through professional team refined management.
• 中国-南亚博览会 (China-South Asia Expo)minorGTM or Marketing PartnerBohao Biotechnology participated in the 10th China-South Asia Expo, setting up in the Medical and Health Care Hall (10-T21 booth) to showcase health products including lutein soft capsules,姜黄朝鲜蓟 beverages, and lutein ester functional beverages.

Scale indicators26 records

Recent moves8 records

Expansion highlights7 records

Broad incumbents

• dsm-firmenich: Global leader in nutrition, health, and specialty ingredients including lutein production for food, beverage, and supplement applications. Comparable as the global incumbent competitor to Yunnan Bohao Biotechnology in marigold-derived lutein, with broader product portfolios, more diversified geographic reach, and stronger customer relationships with multinational food and supplement brands.
• Shanghai Pharmaceuticals Holding: One of China's largest integrated pharmaceutical groups with manufacturing, distribution, and retail pharmacy operations. Both companies operate province-anchored pharmaceutical manufacturing and distribution arms, though Shanghai Pharma has substantially larger scale and international footprint.
• China National Pharmaceutical Group (Sinopharm): China's largest pharmaceutical and healthcare distribution group with extensive wholesale, retail pharmacy, and logistics operations. Yunnan Plant Pharmaceutical already collaborates with Sinopharm on TCM resource synergy, and both groups operate provincial-scale pharmaceutical distribution businesses serving hospitals and pharmacies across China.
• China Resources Pharmaceutical Group: Larger central state-owned pharmaceutical holding company with a similar mix of TCM, chemical drugs, pharmaceutical distribution, and retail pharmacy operations. Comparable as a state-backed pharmaceutical conglomerate but with materially greater scale, broader geographic reach, and more extensive R&D pipeline.

Direct peers

• Yunnan Baiyao Group: Yunnan-based TCM and pharmaceutical manufacturer with a similar provincial-resource-driven strategy. Both leverage Yunnan's medicinal plant biodiversity and operate proprietary Chinese medicine brands alongside chemical drug portfolios, competing directly for TCM market share and inclusion in the National Medical Insurance Catalog.
• Inspur Group: Major Chinese IT hardware and server manufacturer with significant Xin Chuang portfolio and Huawei ecosystem partnership. Both companies compete in the domestic server, PC, and printer hardware markets targeting Chinese state-owned enterprise and government customers as part of the Xin Chuang substitution mandate.
• Yonyou Network Technology: China's leading enterprise software and cloud services provider with deep banking, financial, and large-enterprise customer footprint. Comparable as a domestic enterprise IT vendor serving Chinese financial institutions and large SOEs, with overlapping AI/fintech solution offerings and direct competition for digital transformation mandates.
• Digital China Group: Major Chinese IT services and distribution company with strong banking and financial sector exposure. Both companies deliver IT solutions to Chinese state-owned banks, participate in the Xin Chuang ecosystem, and compete for core banking system transformation contracts; Nantian and Digital China frequently appear together on bank-side RFPs.
• Sunline Tech: Specialist banking IT vendor focused on core banking systems, digital banking, and financial AI solutions for Chinese banks. Direct competitor to Nantian Information for core banking system transformation, risk strategy platforms, and digital banking projects at city commercial and joint-stock banks.

Others

• China General Technology Group: Central state-owned enterprise holding group overseeing manufacturing, pharmaceutical, healthcare, and technology businesses with similarly diversified portfolios. Comparable as a peer Chinese SOE holding group navigating multi-segment industrial operations, though focused on different end markets (machinery, medical imaging, pharmaceutical manufacturing equipment).

Market position

Strengths5 records

Weaknesses4 records

Competitive moat6 records

Key risks7 records

Key highlights7 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries18 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments3 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Yunnan Industrial Investment Holding Group